University of Arkansas: Breast Neoplasms trials

The registry lists 20 Breast Neoplasms studies with University of Arkansas as lead sponsor. 1 are open to participants now and 8 have results posted.

Phase 1 6Phase 2 10Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsRecruitingNCT01530373Phase 2
• Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase InhibitorsTerminatedNCT04493333Phase 2Results posted
• Vaccination of Triple Negative Breast Cancer PatientsCompletedNCT02938442Phase 1/2Results posted
• Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast CancerTerminatedNCT02696759Not applicableResults posted
• Vaccination of High Risk Breast Cancer Patients - A Combined Phase I/II Feasibility-and-Efficacy StudyCompletedNCT02229084Phase 1/2Results posted
• Vaccination of High Risk Breast Cancer PatientsCompletedNCT01390064Phase 1Results posted
• Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-operationCompletedNCT00571987Phase 1/2Results posted
• Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal TherapyTerminatedNCT00570258Phase 2Results posted
• Primary Systemic Therapy in Operable/Locally Advanced Breast CancerCompletedNCT00203502Phase 2Results posted
• A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical FrameworkCompletedNCT06461416Not applicable
• Nurse-led Mind-body Intervention on Sexual Health for Breast Cancer SurvivorsCompletedNCT06307470Not applicable
• Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive SurgeryWithdrawnNCT02372305Phase 4
• Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase InhibitorsCompletedNCT01431872
• Excision Followed by Radiofrequency Ablation for Breast CancerActive, not recruitingNCT01153035Not applicable
• Deep Sequencing of the Breast Cancer TranscriptomeWithdrawnNCT01141530
• Histologic Diagnoses of Incidentally Detected Lesions on MRIWithdrawnNCT00579735
• Use of Breast MRI for Local StagingWithdrawnNCT00579319
• Hydralazine as Demethylating Agent in Breast CancerWithdrawnNCT00575978Phase 1/2
• Percutaneous Removal and Margin Ablation for Breast CancerCompletedNCT00574301Phase 1/2
• Axillary Reverse MappingActive, not recruitingNCT00572481Phase 2